These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38252289)

  • 1. Anti-factor B antibodies in atypical hemolytic uremic syndrome.
    Khandelwal P; Nambiar S; Saini R; Saini S; Coshic P; Sinha A; Hari P; Palanichamy JK; Bagga A
    Pediatr Nephrol; 2024 Jun; 39(6):1909-1916. PubMed ID: 38252289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis.
    Aradottir SS; Kristoffersson AC; Roumenina LT; Bjerre A; Kashioulis P; Palsson R; Karpman D
    Front Immunol; 2021; 12():690821. PubMed ID: 34177949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Osborne AJ; Breno M; Borsa NG; Bu F; Frémeaux-Bacchi V; Gale DP; van den Heuvel LP; Kavanagh D; Noris M; Pinto S; Rallapalli PM; Remuzzi G; Rodríguez de Cordoba S; Ruiz A; Smith RJH; Vieira-Martins P; Volokhina E; Wilson V; Goodship THJ; Perkins SJ
    J Immunol; 2018 Apr; 200(7):2464-2478. PubMed ID: 29500241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN.
    Marinozzi MC; Roumenina LT; Chauvet S; Hertig A; Bertrand D; Olagne J; Frimat M; Ulinski T; Deschênes G; Burtey S; Delahousse M; Moulin B; Legendre C; Frémeaux-Bacchi V; Le Quintrec M
    J Am Soc Nephrol; 2017 May; 28(5):1603-1613. PubMed ID: 28096309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Characterization of Rare Genetic Variants in the N-Terminus of Complement Factor H in aHUS, C3G, and AMD.
    Wong EKS; Hallam TM; Brocklebank V; Walsh PR; Smith-Jackson K; Shuttleworth VG; Cox TE; Anderson HE; Barlow PN; Marchbank KJ; Harris CL; Kavanagh D
    Front Immunol; 2020; 11():602284. PubMed ID: 33519811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
    Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
    J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic investigation of Nordic patients with complement-mediated kidney diseases.
    Rydberg V; Aradottir SS; Kristoffersson AC; Svitacheva N; Karpman D
    Front Immunol; 2023; 14():1254759. PubMed ID: 37744338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database.
    Puraswani M; Khandelwal P; Saini H; Saini S; Gurjar BS; Sinha A; Shende RP; Maiti TK; Singh AK; Kanga U; Ali U; Agarwal I; Anand K; Prasad N; Rajendran P; Sinha R; Vasudevan A; Saxena A; Agarwal S; Hari P; Sahu A; Rath S; Bagga A
    Front Immunol; 2019; 10():1282. PubMed ID: 31231391
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infection.
    Khandelwal P; Krishnasamy S; Govindarajan S; Kumar M; Marik B; Sinha A; Hari P; Bagga A
    Pediatr Nephrol; 2022 Sep; 37(9):2151-2156. PubMed ID: 35089377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Factor I Variants in Complement-Mediated Renal Diseases.
    Zhang Y; Goodfellow RX; Ghiringhelli Borsa N; Dunlop HC; Presti SA; Meyer NC; Shao D; Roberts SM; Jones MB; Pitcher GR; Taylor AO; Nester CM; Smith RJH
    Front Immunol; 2022; 13():866330. PubMed ID: 35619721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
    Donadelli R; Pulieri P; Piras R; Iatropoulos P; Valoti E; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2018; 9():2329. PubMed ID: 30487789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2019; 10():853. PubMed ID: 31118930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare genetic variant in the CFB gene presenting as atypical hemolytic uremic syndrome and immune complex diffuse membranoproliferative glomerulonephritis, with crescents, successfully treated with eculizumab.
    Alfakeeh K; Azar M; Alfadhel M; Abdullah AM; Aloudah N; Alsaad KO
    Pediatr Nephrol; 2017 May; 32(5):885-891. PubMed ID: 28210841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete functional characterization of disease-associated genetic variants in the complement factor H gene.
    Merinero HM; García SP; García-Fernández J; Arjona E; Tortajada A; Rodríguez de Córdoba S
    Kidney Int; 2018 Feb; 93(2):470-481. PubMed ID: 28941939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
    Holle J; Berenberg-Goßler L; Wu K; Beringer O; Kropp F; Müller D; Thumfart J
    Pediatr Nephrol; 2018 Dec; 33(12):2289-2298. PubMed ID: 30238151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
    Noris M; Donadelli R; Remuzzi G
    Pediatr Nephrol; 2019 Aug; 34(8):1311-1323. PubMed ID: 29948306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature.
    Manenti L; Gnappi E; Vaglio A; Allegri L; Noris M; Bresin E; Pilato FP; Valoti E; Pasquali S; Buzio C
    Nephrol Dial Transplant; 2013 Sep; 28(9):2246-59. PubMed ID: 23787552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome.
    Cugno M; Berra S; Depetri F; Tedeschi S; Griffini S; Grovetti E; Caccia S; Cresseri D; Messa P; Testa S; Giglio F; Peyvandi F; Ardissino G
    J Am Soc Nephrol; 2021 May; 32(5):1227-1235. PubMed ID: 33712527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlations of low-frequency variants in the complement system in renal disease and age-related macular degeneration.
    Geerlings MJ; Volokhina EB; de Jong EK; van de Kar N; Pauper M; Hoyng CB; van den Heuvel LP; den Hollander AI
    Clin Genet; 2018 Oct; 94(3-4):330-338. PubMed ID: 29888403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor H Autoantibodies and Complement-Mediated Diseases.
    Zhang Y; Ghiringhelli Borsa N; Shao D; Dopler A; Jones MB; Meyer NC; Pitcher GR; Taylor AO; Nester CM; Schmidt CQ; Smith RJH
    Front Immunol; 2020; 11():607211. PubMed ID: 33384694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.